|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1455 PENNSYLVANIA AVENUE, NW |
Address2 | SUITE 925 |
City | WASHINGTON |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Natick |
State | MA |
Zip Code | 01760 |
Country | USA |
|
5. Senate ID# 66716-12
|
||||||||
|
6. House ID# 355670000
|
TYPE OF REPORT | 8. Year | 2008 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Steven N. LaPierre, Director of Legislative Affairs |
Date | 01/16/2009 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
- HR 6331 Medicare Improvements for Patients and Providers Act of 2008, possible inclusion of remote monitoring provisions.
- HR 5765 Medicare Remote Monitoring Access Act, a bill to provide Medicare reimbursement for doctors who remotely monitor chronically ill patients.
- HR 2994 National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies.
- S. 3387 National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies.
- S. 631 Remote Monitoring Access Act of 2007a bill to provide Medicare reimbursement for doctors who remotely monitor chronically ill patients.
- S. 2029 Physican Payments Sunshine Act, a bill that would require disclosure of the relationships between physicians and the manufacturers of drugs and devices.
- HR 5605 Physican Payments Sunshine Act, a bill that would require disclosure of the relationships between physicians and the manufacturers of drugs and devices.
- Medicare Coverage of Intracranial Angioplasty and Stenting.
- Medicare Payment of Inpatient Hospital Services.
- Medicare Coverage of Renal Stenting.
- Medicare Coverage of Carotid Stenting.
- Regulatory and Reimbursement Issues for Medical Devices in Medicare.
- S. 3408 Comparative Effectiveness Research Act to compare cinical effectiveness of medical treatments, services and items.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Office of Management & Budget (OMB), Medicare Payment Advisory Commission (MedPAC), Congressional Budget Office (CBO)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Steven |
LaPierre |
|
|
|
Michael |
Mattoon |
|
|
|
Scott |
Reid |
|
|
|
Brenda |
Becker |
|
Assistant to the Vice President for Leg. Affairs |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
- Food and Drug Administration Globalization Act of 2008, a bill to increase FDA inspection of manufacturers in the US and abroad.
- HR 6381Medical Device Safety Act of 2008, a bill that would remove federal preemption protection for certain medical devices.
- HR 2900 Implementation of Food and Drug Administration Amendments Act of 2007, a bill to revise and extend the user-fee programs for prescription drugs and for medical devices.
- HR 3014 Health Disparities, a bill to address disparities in the delivery of health care, specifically as it relates to cardiovascular care.
- S. 3398 Medical Device Safety Act of 2008, a bill that would remove federal preemption protection for certain medical devices.
- HR 6432 Animal Drug User Fee Act, a provision to make technical corrections to device user fee program.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Government Accountability Office (GAO), Office of Management & Budget (OMB), Medicare Payment Advisory Commission (MedPAC), Congressional Budget Office (CBO)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Steven |
LaPierre |
|
|
|
Scott |
Reid |
|
|
|
Michael |
Mattoon |
|
|
|
Brenda |
Becker |
|
Assistant to Vice President for Leg. Affairs |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
- S.1145 Patent Reform Act of 2007, provisions related specifically to innovative technologies.
- HR 1908 Patent Reform Act of 2007, provisions related specifically to innovative technologies.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Patent & Trademark Office (PTO)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Steven |
LaPierre |
|
|
|
Michael |
Mattoon |
|
|
|
Brenda |
Becker |
|
Assistant to Vice President for Leg. Affairs |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
- HR 2138 Investment in America Act of 2007, a bill to permanently extend and strentghen the R&D tax credit.
- S. 2209 Investment in America Act of 2007, a bill to permanently extend and strentghen the R&D tax credit.
- HR 1424 Emergency Economic Stabilization Act of 2008, a bill to permanently extend and strentghen the R&D tax credit.
- HR 6049 Energy Improvement and Extension Act of 2008, a bill to permanently extend and strentghen the R&D tax credit.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Steven |
LaPierre |
|
|
|
Michael |
Mattoon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
- S. 2160 Veterans Pain Care Act, a bill to promote greater access to chronic pain therapies in the VA medical system.
- HR 6122 Veterans Pain Care Act, a bill to promote greater access to chronic pain therapies in the VA medical system.
- S. 2162 Veterans Mental Health and Other Care Improvements Act, a bill to promote greater access to chronic pain therapies in the VA medical system.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Steven |
LaPierre |
|
|
|
Michael |
Mattoon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRD
16. Specific lobbying issues
- Market Access, regulatory approvals and reimbursement for medical devices in Japan, EU, Korea, China, Brazil.
- Trade Agreements with Columbia, South Korea.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Commerce - Dept of (DOC), U.S. Trade Representative (USTR), State - Dept of (DOS), Treasury - Dept of, Intl Trade Administration (ITA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Steven |
LaPierre |
|
|
|
Paul |
Barry |
|
|
|
Michael |
Mattoon |
|
|
|
Brenda |
Becker |
|
Assistant to Vice President for Leg. Affairs |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
- HR 5465 Military Pain Care Act, a bill to promote greater access to chronic pain therapies in the DoD healthcare system.
- HR 5658 Duncan Hunter National Defense Authorization Act for Fiscal Year 2009, provisions to promote greater access to chronic pain therapies in the DoD healthcare system.
- S. 3002 Department of Defense Authorization Act, provisions to promote greater access to chronic pain therapies in the DoD healthcare system.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Steven |
LaPierre |
|
|
|
Michael |
Mattoon |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |